5Bone RC,Balk RA,Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference. American Collage of Chest Physicians/Society of Critical Care Medicine[J]. Chest, 1992,101 : 1644-1655.
6Blackwell TS, Christman JW. Sepsis and cytokine: current status[J]. Br J Anaesth, 1996,77:110-117.
7Levy MM,Fink MP,Marshall JC,et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference[J]. Crit Care Med,2003,31:1250-1256.
8Watanabe T, Sato Y, Ichida T, et al. Comparison of urinary ulinastatin levels between donors and recipients immediately following adult living related donor liver transplantation[J].Transplantation Proc, 2003,35: 76-77.
9Tani T,Aoki H,Yoshioka T,et al. Treatment of septic shock with a protease inhibitor in a canine model:a prospective, randomized, controlled trail [J]. Crit Care Med, 1993, 21: 925-930.
10Aosasa S,Ono S,Mochizuki H,et al. Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes[J]. Shock, 2001,15 : 101-105.
